Evidence map›Paper›PMID 40828547›Full record

ArticleInternational journal of geriatric psychiatry2025

The Relationship of Alzheimer's Disease and Related Dementias Blood-Based Biomarkers and Informant-Reported Neuropsychiatric Symptoms Differs by Informant Type in Older Adults Without Dementia.

Julia R Bacci, Marc D Rudolph, Suzanne Craft, James R Bateman, Samuel N Lockhart, Michelle M Mielke

Abstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia R BacciDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0009-0005-7408-0984
Marc D RudolphDepartment of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0001-7046-1169
Suzanne CraftDepartment of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
James R BatemanDepartment of Neurology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Samuel N LockhartDepartment of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Michelle M MielkeDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0001-7177-1185

Funding

Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC NetworkU24AG082930 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicole R. Fowler, Thomas K Karikari · 2023 to 2026
$7.3M
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementiasRF1AG079397 · NIA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI MIELKE, MICHELLE M, MURRAY, ANNE M · 2022 to 2024
$4.5M
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African AmericansRF1AG077386 · NIA · UNIVERSITY OF GEORGIA · PI MIELKE, MICHELLE M, SIMONS, RONALD L · 2022 to 2023
$3.2M
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementiasRF1AG069052 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, MIELKE, MICHELLE M · 2021 to 2021
$2.4M
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s DiseaseR01AG077386 · NIA · UNIVERSITY OF GEORGIA · PI Steven R Beach, Michelle M Mielke · 2025 to 2026
$1.6M
Neuroscience Training at Wake ForestT32NS115704 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CZOTY, PAUL W. · 2021 to 2025
$1.4M
Astrophysics DivisionNIA NIH HHS P30 AG072947NIA NIH HHS R01 AG077386NIA NIH HHS RF1 AG069052NIA NIH HHS RF1 AG077386NIA NIH HHS RF1 AG079397NIA NIH HHS U24 AG082930NIH HHS P30 AG072947NIH HHS RF1 AG077386NIH HHS RF1 AG079397NIH HHS RF1 AG69052NIH HHS T32 NS115704NIH HHS U24 AG082930NINDS NIH HHS T32 NS115704
6 · The paper itself

Abstract

objectivesIn a sample of community-dwelling older adults, we examined the association of Alzheimer's Disease and Related Dementias (AD/ADRD) blood-based biomarkers (BBMs) and neuropsychiatric symptoms (NPS) and whether informant type (i.e., spouse vs. child vs. other) modified that association.

methodsThis study included 430 participants with a cognitively unimpaired or mild cognitive impairment consensus diagnosis from the Wake Forest Alzheimer's Disease Research Center Clinical Core cohort. Informants reported NPS using the Neuropsychiatric Inventory Questionnaire. AD/ADRD BBMs included the Aβ42/40 ratio, p-tau181, p-tau217, NfL, and GFAP. Generalized linear models were used to examine the associations between AD/ADRD BBMs and NPS. Secondary models adjusted for age, sex, education, race, and cognitive status. Tertiary models adjusted for covariates in secondary models, as well as informant type. Interactions between informant type and AD/ADRD BBMs were examined.

resultsHigher p-tau217 was associated with higher NPS in both unadjusted models and models adjusted for demographics and cognitive status. This association was attenuated and no longer statistically significant after additionally adjusting for informant type. Significant interactions of informant type and p-tau181 or p-tau217 on NPS were demonstrated, where p-tau181 or p-tau217 were more strongly associated with NPS reported by children compared to spouses.

conclusionsInformant type modified the association between AD/ADRD BBMs and NPS, with stronger associations observed when symptoms were reported by child informants compared to spouse informants. These findings have important implications for earlier detection of individuals with AD/ADRD pathologies.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementiaAgedAged, 80 and overAmyloid beta-PeptidesBiomarkersFemaleHumansMaleNeuropsychological Teststau ProteinsAmyloid beta-PeptidesBiomarkerstau ProteinsAlzheimer's Disease and Related Dementiasblood‐based biomarkersinformantneuropsychiatric symptoms

Identifiers

PMID40828547
PMCPMC12364018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.